4.2 Article

Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

High Impact of 18F-FDG-PET on Management and Prognostic Stratification of Newly Diagnosed Small Cell Lung Cancer

Arun Azad et al.

MOLECULAR IMAGING AND BIOLOGY (2010)

Article Oncology

Cancer Statistics, 2009

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

F-18-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma

Colleen M. Costelloe et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas

Matthias R. Benz et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Oncology

Metabolic tumor burden predicts for disease progression and death in lung cancer

Percy Lee et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Oncology

FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer

Lilie L. Lin et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Review Medicine, General & Internal

Small-cell lung cancer

DM Jackman et al.

LANCET (2005)

Article Oncology

Impact of positron emission tomography on the management of patients with small-cell lung cancer - Preliminary experience

R Blum et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer

I Brink et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)